DK0699068T3 - Reduktion af liposominducerede fysiologiske bivirkninger - Google Patents

Reduktion af liposominducerede fysiologiske bivirkninger

Info

Publication number
DK0699068T3
DK0699068T3 DK94918106T DK94918106T DK0699068T3 DK 0699068 T3 DK0699068 T3 DK 0699068T3 DK 94918106 T DK94918106 T DK 94918106T DK 94918106 T DK94918106 T DK 94918106T DK 0699068 T3 DK0699068 T3 DK 0699068T3
Authority
DK
Denmark
Prior art keywords
liposome
reduction
side effects
animal
physiological side
Prior art date
Application number
DK94918106T
Other languages
English (en)
Inventor
Patrick L Ahl
Suresh K Bhatia
Sharma R Minchey
Andrew S Janoff
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of DK0699068T3 publication Critical patent/DK0699068T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
DK94918106T 1993-05-21 1994-05-20 Reduktion af liposominducerede fysiologiske bivirkninger DK0699068T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6592893A 1993-05-21 1993-05-21
US20765194A 1994-03-07 1994-03-07
PCT/US1994/005824 WO1994027580A1 (en) 1993-05-21 1994-05-20 Reduction of liposome-induced adverse physiological reactions

Publications (1)

Publication Number Publication Date
DK0699068T3 true DK0699068T3 (da) 2002-03-11

Family

ID=26746185

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94918106T DK0699068T3 (da) 1993-05-21 1994-05-20 Reduktion af liposominducerede fysiologiske bivirkninger

Country Status (15)

Country Link
US (2) US5614214A (da)
EP (2) EP1118326A3 (da)
JP (1) JPH08510748A (da)
KR (1) KR960702297A (da)
AT (1) ATE210966T1 (da)
AU (1) AU680513B2 (da)
CA (1) CA2160118A1 (da)
DE (2) DE69429511T2 (da)
DK (1) DK0699068T3 (da)
ES (2) ES2165875T3 (da)
GR (1) GR20010300075T1 (da)
NO (1) NO954691L (da)
NZ (1) NZ267310A (da)
PT (1) PT699068E (da)
WO (1) WO1994027580A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ128096A3 (en) * 1993-11-04 1997-08-13 Schering Ag Charged liposome preparation
US5820873A (en) * 1994-09-30 1998-10-13 The University Of British Columbia Polyethylene glycol modified ceramide lipids and liposome uses thereof
US5885613A (en) * 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
KR100381449B1 (ko) * 1994-10-14 2003-07-18 더 리포좀 컴퍼니, 인코퍼레이티드 에테르지질리포좀과이들의제약학적용도
US6673364B1 (en) 1995-06-07 2004-01-06 The University Of British Columbia Liposome having an exchangeable component
USRE39042E1 (en) * 1996-02-16 2006-03-28 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US5965159A (en) 1996-02-16 1999-10-12 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US6007839A (en) * 1996-02-16 1999-12-28 The Liposome Company, Inc. Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes
US5942246A (en) * 1996-02-16 1999-08-24 The Liposome Company, Inc. Etherlipid containing multiple lipid liposomes
US20030199425A1 (en) * 1997-06-27 2003-10-23 Desai Neil P. Compositions and methods for treatment of hyperplasia
US6734171B1 (en) 1997-10-10 2004-05-11 Inex Pharmaceuticals Corp. Methods for encapsulating nucleic acids in lipid bilayers
EP0976394A1 (en) * 1998-07-30 2000-02-02 Biosearch Italia S.p.A. New injectable formulations
US6593308B2 (en) * 1999-12-03 2003-07-15 The Regents Of The University Of California Targeted drug delivery with a hyaluronan ligand
AU2002312777B2 (en) * 2001-03-27 2007-07-05 Phares Pharmaceutical Research N.V. Method and composition for solubilising a biologically active compound with low water solubility
JP2005525992A (ja) * 2001-06-25 2005-09-02 イサム・リサーチ・デベロツプメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシテイ・オブ・エルサレム 生物学的物質を充填した小胞の調製法およびそれらの様々な使用
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
US6811777B2 (en) 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US7462703B2 (en) * 2003-01-31 2008-12-09 Max-Delbruck-Centrum Fur Molekulare Medizin Agent for gene transfer
CN1319520C (zh) * 2005-02-03 2007-06-06 上海交通大学 核苷膦酸类化合物的脂质体和脂质复合物制剂
US8080262B2 (en) * 2006-10-24 2011-12-20 Northwestern University Encapsulated peptide amphiphile nanostructures
US20100112081A1 (en) 2008-10-07 2010-05-06 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
EP2486923B1 (en) * 2011-02-11 2015-09-09 Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG Histone deacetylase (HDAC) inhibiting compounds and method of making same
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation
US20210154307A1 (en) * 2019-11-07 2021-05-27 Northeastern University Cationic nanostructures for intra-cartilage delivery of therapeutics and contrast agents

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577446A (en) * 1968-09-09 1971-05-04 American Home Prod Phosphatidylalkanolamine derivatives
US3993754A (en) * 1974-10-09 1976-11-23 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome-encapsulated actinomycin for cancer chemotherapy
US4086257A (en) * 1976-10-12 1978-04-25 Sears Barry D Phosphatidyl quaternary ammonium compounds
CH624011A5 (da) * 1977-08-05 1981-07-15 Battelle Memorial Institute
CH621479A5 (da) * 1977-08-05 1981-02-13 Battelle Memorial Institute
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US5030453A (en) * 1983-03-24 1991-07-09 The Liposome Company, Inc. Stable plurilamellar vesicles
WO1985000968A1 (en) * 1983-09-06 1985-03-14 Health Research, Inc. Liposome delivery method for decreasing the toxicity of an antitumor drug
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
CA1264668A (en) * 1984-06-20 1990-01-23 Pieter R. Cullis Extrusion techniques for producing liposomes
US5008050A (en) * 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
CA1270198C (en) * 1984-08-08 1990-06-12 Marcel B Bally ENCAPSULATION OF ANTINEOPLASTIC AGENTS IN LIPOSONES
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
JPS6188887A (ja) * 1984-10-08 1986-05-07 Meito Sangyo Kk 酵素法１−ｏ−アルキル−２−アシルグリセロリン脂質誘導体の製法
US4975282A (en) * 1985-06-26 1990-12-04 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
EP0231261B1 (en) * 1985-07-05 1994-04-06 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
PH26160A (en) * 1985-08-19 1992-03-18 Univ Texas Pharmaceutical compositions consisting of acylated phospholipids
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
CH672733A5 (da) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
US5080833A (en) * 1987-09-21 1992-01-14 Kabushiki Kaisha Toshiba Immobilization of bioactive substance on lipid composition containing modified lipid compound
WO1990014105A1 (en) * 1989-05-15 1990-11-29 The Liposome Company, Inc. Accumulation of drugs into liposomes by a proton gradient
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
DK0555317T3 (da) * 1990-10-09 1995-08-07 Nexstar Pharmaceuticals Inc Phospholipid-analog-vesikel med en succinimidylsubstituent
US5313804A (en) * 1993-04-23 1994-05-24 Maritime Geothermal Ltd. Direct expansion geothermal heat pump

Also Published As

Publication number Publication date
DE1118326T1 (de) 2002-04-18
EP0699068B1 (en) 2001-12-19
GR20010300075T1 (en) 2001-12-31
JPH08510748A (ja) 1996-11-12
NZ267310A (en) 1996-09-25
ATE210966T1 (de) 2002-01-15
CA2160118A1 (en) 1994-12-08
NO954691D0 (no) 1995-11-20
AU680513B2 (en) 1997-07-31
US5662930A (en) 1997-09-02
ES2165875T3 (es) 2002-04-01
WO1994027580A1 (en) 1994-12-08
EP1118326A2 (en) 2001-07-25
US5614214A (en) 1997-03-25
KR960702297A (ko) 1996-04-27
PT699068E (pt) 2002-06-28
AU6956894A (en) 1994-12-20
ES2193005T1 (es) 2003-11-01
EP1118326A3 (en) 2002-07-31
EP0699068A1 (en) 1996-03-06
NO954691L (no) 1995-11-20
DE69429511T2 (de) 2002-05-16
DE69429511D1 (de) 2002-01-31

Similar Documents

Publication Publication Date Title
DK0699068T3 (da) Reduktion af liposominducerede fysiologiske bivirkninger
OA09850A (fr) Conjugués d'interféron et composés les contenant.
AU696851B2 (en) Method of treating hyperproliferative vascular disease
FI891592A0 (fi) Hudvaordskomposition och foerfarande foer dess framstaellning.
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
DE59109222D1 (de) Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen
NO894201L (no) Badetilsetningsmiddel.
ATE223204T1 (de) Liposomenzusammensetzung
DE69806962T2 (de) FSNMU als entzündungshemmende Mittel in den oberflächen Geweben von Säugetieren
DK0631772T3 (da) Retinoidholdig sammensætning
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
ES2084753T3 (es) Niclosamida en locion topica.
WO1991015200A3 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
DE69008261T2 (de) Kosmetische Präparate.
CA2170289A1 (en) A method of treating liver disease and like indications with vasodilating agents
NO994930D0 (no) Preventiver og hjelpemidler for ulcerös kolitt og/eller crohn's sykdom
SG168394G (en) Method and formulation for orally administering bioactive agents to and through the peyer's patch
ES1021297Y (es) Juego infantil de composicion.